First Time Loading...

Precigen Inc
NASDAQ:PGEN

Watchlist Manager
Precigen Inc Logo
Precigen Inc
NASDAQ:PGEN
Watchlist
Price: 1.4 USD 1.45% Market Closed
Updated: Apr 24, 2024

Intrinsic Value

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. [ Read More ]

The intrinsic value of one PGEN stock under the Base Case scenario is 9.14 USD. Compared to the current market price of 1.4 USD, Precigen Inc is Undervalued by 85%.

Key Points:
PGEN Intrinsic Value
Base Case
9.14 USD
Undervaluation 85%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Precigen Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PGEN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Precigen Inc

Provide an overview of the primary business activities
of Precigen Inc.

What unique competitive advantages
does Precigen Inc hold over its rivals?

What risks and challenges
does Precigen Inc face in the near future?

Has there been any significant insider trading activity
in Precigen Inc recently?

Summarize the latest earnings call
of Precigen Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Precigen Inc.

Provide P/S
for Precigen Inc.

Provide P/E
for Precigen Inc.

Provide P/OCF
for Precigen Inc.

Provide P/FCFE
for Precigen Inc.

Provide P/B
for Precigen Inc.

Provide EV/S
for Precigen Inc.

Provide EV/GP
for Precigen Inc.

Provide EV/EBITDA
for Precigen Inc.

Provide EV/EBIT
for Precigen Inc.

Provide EV/OCF
for Precigen Inc.

Provide EV/FCFF
for Precigen Inc.

Provide EV/IC
for Precigen Inc.

Show me price targets
for Precigen Inc made by professional analysts.

What are the Revenue projections
for Precigen Inc?

How accurate were the past Revenue estimates
for Precigen Inc?

What are the Net Income projections
for Precigen Inc?

How accurate were the past Net Income estimates
for Precigen Inc?

What are the EPS projections
for Precigen Inc?

How accurate were the past EPS estimates
for Precigen Inc?

What are the EBIT projections
for Precigen Inc?

How accurate were the past EBIT estimates
for Precigen Inc?

Compare the revenue forecasts
for Precigen Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Precigen Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Precigen Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Precigen Inc compared to its peers.

Compare the P/E ratios
of Precigen Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Precigen Inc with its peers.

Analyze the financial leverage
of Precigen Inc compared to its main competitors.

Show all profitability ratios
for Precigen Inc.

Provide ROE
for Precigen Inc.

Provide ROA
for Precigen Inc.

Provide ROIC
for Precigen Inc.

Provide ROCE
for Precigen Inc.

Provide Gross Margin
for Precigen Inc.

Provide Operating Margin
for Precigen Inc.

Provide Net Margin
for Precigen Inc.

Provide FCF Margin
for Precigen Inc.

Show all solvency ratios
for Precigen Inc.

Provide D/E Ratio
for Precigen Inc.

Provide D/A Ratio
for Precigen Inc.

Provide Interest Coverage Ratio
for Precigen Inc.

Provide Altman Z-Score Ratio
for Precigen Inc.

Provide Quick Ratio
for Precigen Inc.

Provide Current Ratio
for Precigen Inc.

Provide Cash Ratio
for Precigen Inc.

What is the historical Revenue growth
over the last 5 years for Precigen Inc?

What is the historical Net Income growth
over the last 5 years for Precigen Inc?

What is the current Free Cash Flow
of Precigen Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Precigen Inc.

Financials

Balance Sheet Decomposition
Precigen Inc

Current Assets 68.8m
Cash & Short-Term Investments 62.9m
Receivables 1.6m
Other Current Assets 4.3m
Non-Current Assets 82.3m
PP&E 14.2m
Intangibles 67.3m
Other Non-Current Assets 767k
Current Liabilities 23m
Accounts Payable 1.7m
Accrued Liabilities 20.8m
Other Current Liabilities 509k
Non-Current Liabilities 9.6m
Other Non-Current Liabilities 9.6m
Efficiency

Earnings Waterfall
Precigen Inc

Revenue
6.2m USD
Cost of Revenue
-6.1m USD
Gross Profit
106k USD
Operating Expenses
-89m USD
Operating Income
-88.9m USD
Other Expenses
-7m USD
Net Income
-95.9m USD

Free Cash Flow Analysis
Precigen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

PGEN Profitability Score
Profitability Due Diligence

Precigen Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
ROE is Increasing
Negative 1-Year Revenue Growth
20/100
Profitability
Score

Precigen Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

PGEN Solvency Score
Solvency Due Diligence

Precigen Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Precigen Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PGEN Price Targets Summary
Precigen Inc

There are no price targets for PGEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PGEN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PGEN Price
Precigen Inc

1M 1M
0%
6M 6M
+26%
1Y 1Y
+21%
3Y 3Y
-83%
5Y 5Y
-68%
10Y 10Y
-93%
Annual Price Range
1.4
52w Low
0.8901
52w High
1.85
Price Metrics
Average Annual Return -1.09%
Standard Deviation of Annual Returns 74.43%
Max Drawdown -92%
Shares Statistics
Market Capitalization 348.5m USD
Shares Outstanding 248 919 008
Percentage of Shares Shorted 11.44%

PGEN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Precigen Inc Logo
Precigen Inc

Country

United States of America

Industry

Biotechnology

Market Cap

348.5m USD

Dividend Yield

0%

Description

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. The company is headquartered in Germantown, Maryland and currently employs 456 full-time employees. The company went IPO on 2013-08-08. Its therapeutic platforms, including UltraCAR-T, AdenoVerse immunotherapy, and ActoBiotics, are designed to precisely control the level and physiological location of gene expression and modify biological molecules to control the function and output of living cells to treat underlying disease conditions. The Company’s lead clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. The firm also completed a Phase I study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform. The company also has a robust pipeline of preclinical programs.

Contact

MARYLAND
Germantown
20374 Seneca Meadows Parkway
+13015569900.0
https://precigen.com/

IPO

2013-08-08

Employees

456

Officers

Executive Chairman
Mr. Randal J. Kirk J.D.
President, CEO & Director
Dr. Helen Sabzevari Ph.D.
Chief Financial Officer
Mr. Harry Thomasian Jr.
Chief Operating Officer
Mr. Rutul R. Shah
Chief Legal Officer & Corporate Secretary
Mr. Donald P. Lehr
Senior Vice President of Intellectual Property Affairs
Mr. Jeffrey Thomas Perez
Show More
VP & Head of Investor Relations
Mr. Steven Harasym
VP & Head of Human Resources
Mr. Rob Russell
Senior VP & Head of Research
Dr. Douglas E. Brough Ph.D.
Senior VP & Head of CMC
Dr. Bryan T. Butman Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one PGEN stock?

The intrinsic value of one PGEN stock under the Base Case scenario is 9.14 USD.

Is PGEN stock undervalued or overvalued?

Compared to the current market price of 1.4 USD, Precigen Inc is Undervalued by 85%.